Invesco QQQ Trust, Series 1 (QQQ) vs Sanofi (SNY)
Over the past 10 years, SNY lagged QQQ — 5.69% vs 20.81% annualized total return (price plus dividends).
A side-by-side comparison of Invesco QQQ Trust, Series 1 and Sanofi across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.
Total return — QQQ vs SNY
growth of $100 · dividends reinvested · last 10yMetrics side by side
Did SNY beat QQQ?
Over the past 10 years, SNY lagged QQQ — 5.69% vs 20.81% annualized total return (price plus dividends).
Total return (annualized)
| Metric | QQQ | SNY |
|---|---|---|
| Total return (1Y) | 26.36% | -5.53% |
| Total return CAGR (3Y) | 26.25% | -1.21% |
| Total return CAGR (5Y) | 14.59% | 1.38% |
| Total return CAGR (10Y) | 20.81% | 5.69% |
QQQ is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has SNY beaten QQQ?
- Over the past 10 years, SNY lagged QQQ — 5.69% vs 20.81% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.